Perinatal depression continues to affect 15% to 20% of all birthing people, with rates up to 40% in marginalized communities. The effects on the parent, fetus, newborn infant, and entire family are profound and can include preterm delivery, low birth weight, decreased breastfeeding, and maternal suicide, to name a few. While most people suffering from perinatal depression can be treated with non-medication approaches alone, such as psychotherapy, some require pharmacology in order to recover. Fortunately, an increasingly robust evidence base provides us with reassuring data on how to prescribe for this important and vulnerable population. This webinar will cover principles and models for prescribing, apply them to current antidepressant classes, and review the data behind novel treatments.

For more information on Perinatal Resource to Optimize Mental Health Interventions and Substance Use Treatment Excellence (PROMISE), please view their website.